Form 4: SANUWAVE Health Executive Acquires Stock Options

Iulian Cioanta, Chief Science and Technology Officer at SANUWAVE Health, has acquired stock options through multiple transactions.

Summary

• Iulian Cioanta, the Chief Science and Technology Officer of SANUWAVE Health, has reported several stock option acquisitions.
• On September 20, 2018, Cioanta acquired options to purchase 2,000 shares at $78.75 per share, which are fully vested.
• On August 26, 2019, Cioanta acquired options to purchase 133 shares at $56.25 per share, which are also fully vested.
• On October 22, 2024, Cioanta acquired options to purchase 10,667 shares at $14.20 per share, which will vest over three years in 12 equal quarterly installments.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of stock option grants to an executive. It is neither particularly positive nor negative, but the acquisition of options by an executive is generally seen as a positive sign.

Positives

• The acquisition of stock options by a key executive may indicate confidence in the company's future performance.
• The vesting schedule of the most recent options may incentivize long-term commitment from the executive.

Industry Context

This is a standard SEC Form 4 filing, which is common for publicly traded companies when executives acquire or dispose of company securities. It is a routine disclosure and does not indicate any specific industry trend.

Comparison to Industry Standards

• Stock option grants are a common form of executive compensation in publicly traded companies, particularly in the technology and healthcare sectors.
• The vesting schedule of the 2024 options is typical, aligning executive incentives with long-term company performance.
• The exercise prices of the options are not directly comparable to other companies without knowing the specific circumstances of the grants and the company's stock price at the time of the grants.

Stakeholder Impact

• The stock option grants may have a minor positive impact on shareholder sentiment, as it indicates executive alignment with company performance.

Key Dates

Keywords

stock options, insider trading, executive compensation, SANUWAVE Health, SNWV, Iulian Cioanta